Involvement of α1β1 integrin in insulin-like growth factor-1-mediated protection of PC12 neuronal processes from tumor necrosis factor-α-induced injury

Journal of Neuroscience Research

Volumn 83, Issue 1, 2006, Pages 7-18

  Wang, Jin Ying ^a   Grabacka, Maja ^a,b   Marcinkiewicz, Cezary ^a   Staniszewska, Izabella ^a   Peruzzi, Francesca ^a   Khalili, Kamel ^a   Amini, Shohreh ^a   Reiss, Krzysztof ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

IGF 1; Integrins; Neuronal damage; PC12; TNF

Indexed keywords

COLLAGEN TYPE 4; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE; OBTUSTATIN; PROTEIN INHIBITOR; PROTEIN KINASE B; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 1; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; DISINTEGRIN; SOMATOMEDIN C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; NERVE CELL DEGENERATION; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CELL ADHESION; CELL DIFFERENTIATION; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL DIFFERENTIATION; DISINTEGRINS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR I; INTEGRIN ALPHA1BETA1; PC12 CELLS; PHOSPHORYLATION; PLATELET AGGREGATION INHIBITORS; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30344448866     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20712     Document Type: Article

References (48)

1. Adams TE, Epa VC, Garrett TP, Ward CW. 2000. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57:1050-1093.
2. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. 1997. The IGF-1 receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:F105-F126.
3. Bazan-Socha S, Kisiel DG, Young B, Theakston RD, Calvete JJ, Sheppard D, Marcinkiewicz C. 2004. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins. Biochemistry 43:1639-1647.
4. Broussard SR, McCusker RH, Novakofski JE, Strle K, Shen WH, Johnson RW, Freund GG, Dantzer R, Kelley KW. 2003. Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology 144:2988-2996.
5. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321.
6. Csehi SB, Mathieu S, Seifert U, Lange A, Zweyer M, Wernig A, Adam D. 2005. Tumor necrosis factor (TNF) interferes with insulin signaling through the p55 TNF receptor death domain. Biochem Biophys Res Commun 329:397-405.
7. D'Mello SR, Galli C, Ciotti T, Calissano P. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 90:10989-10993.
8. Digicaylioglu M, Garden G, Timberlake S, Fletcher L, Lipton SA. 2004. Acute neuroprotective synergy of erythropoierin and insulin-like growth factor I. Proc Natl Acad Sci U S A 101:9855-9860.
9. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661-665.
10. Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C, Nikolics K. 1992. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 182:593-599.
11. Guilherme A, Torres K, Czech MP. 1998. Cross-talk between insulin receptor and integrin alpha5 beta1 signaling pathways. J Biol Chem 273:22899-22903.
12. Heck S, Lezoualc'h F, Engert S, Behl C. 1999. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem 274:9828-9835.
13. Hermanto U, Zong CS, Li W, Wang LH. 2002. RACK1, an insulin-like growth factor I (IGF-1) receptor-interacting protein, modulates IGF-1-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol 22:2345-2365.
14. Kisiel DG, Calvete JJ, Katzhendler J, Fertala A, Lazarovici P, Marcinkiewicz C. 2004. Structural determinants of the selectivity of KTS-disintegrins for the alpha1beta1 integrin. FEBS Lett 577:478-482.
15. Kreuz S, Siegmund D, Scheurich P, Wajant H. 2001. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21:3964-3973.
16. LeRoith D, Baserga R, Helman L, Roberts CT, Jr. 1995. Insulin-like growth factors and cancer. Ann Intern Med 122:54-59.
17. Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, Tran JH, Nedospasov SA, Liu ZG. 2004. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279:10822-10828.
18. Lynch L, Vodyanik PI, Boettiger D, Guvakova MA. 2005. Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells. Mol Biol Cell 16:51-63.
19. Maile LA, Clemmons DR. 2002. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-1) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-1 receptor. Endocrinology 143:4259-4264.
20. Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ, Niewiarowski S. 1996. Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem J 317:817-825.
21. Marcinkiewicz C, Weinreb PH, Calvete JJ, Kisiel DG, Mousa SA, Tuszynski GP, Lobb RR. 2003. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res 63:2020-2023.
22. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. 2001. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299-5305.
23. Nio Y, Zighelboim J, Berek J, Bonavida B. 1990. Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells. Cancer Chemother Pharmacol 26:1-8.
24. Nolop KB, Ryan US. 1990. Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide. Am J Physiol 259:L123-L129.
25. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19:7203-7215.
26. Peruzzi F, Prisco M, Morrione A, Valentinis B, Baserga R. 2001. Anti-apoptotic signaling of the IGF-1 receptor through mitochondrial translocation of c-Raf and Nedd4. J Biol Chem 14:14.
27. Reiss K, Porcu P, Sell C, Pietrzkowski Z, Baserga R. 1992. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene 7:2243-2248.
28. Reiss K, Valentinis B, Tu X, Xu SQ, Baserga R. 1998. Molecular markers of IGF-1-mediated mitogenesis. Exp Cell Res 242:361-372.
29. Reiss K, Wang JY, Romano G, Tu X, Peruzzi F, Baserga R. 2001. Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells. Oncogene 20:490-500.
30. Romano G, Reiss K, Tu X, Peruzzi F, Belletti B, Wang JY, Zanocco-Marani T, Baserga R. 2001. Efficient in vitro and in vivo gene regulation of a retrovirally delivered proapoptotic factor under the control of the Drosophila HSP70 promoter. Gene Ther 8:600-607.
31. Russell JW, Feldman EL. 1999. Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Horm Metab Res 31:90-96.
32. Schacher DH, VanHoy RW, Liu Q, Arkins S, Dantzer R, Freund GG, Kelley KW. 2000. Developmental expression of insulin receptor substrate-2 during dimethylsulfoxide-induced differentiation of human HL-60 cells. J Immunol 164:113-120.
33. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. 2003. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3′-kinase/AKT signaling. Cancer Res 63:5850-5858.
34. Tawil NJ, Houde M, Blacher R, Esch F, Reichardt LF, Turner DC, Carbonetto S. 1990. Alpha 1 beta 1 integrin heterodimer functions as a dual laminin/collagen receptor in neural cells. Biochemistry 29:6540-6544.
35. Tomaselli KJ, Damsky CH, Reichardt LF. 1987. Interactions of a neuronal cell line (PC12) with laminin, collagen IV, and fibronectin: identification of integrin-related glycoproteins involved in attachment and process outgrowth. J Cell Biol 105:2347-2358.
36. Tomaselli KJ, Damsky CH, Reichardt LF. 1988. Purification and characterization of mammalian integrins expressed by a rat neuronal cell line (PC12): evidence that they function as alpha/beta heterodimeric receptors for laminin and type IV collagen. J Cell Biol 107:1241-1252.
37. Trojanek J, Ho T, Del Valle L, Nowicki M, Wang JY, Lassak A, Peruzzi F, Khalili K, Skorski T, Reiss K. 2003. Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol 23:7510-7524.
38. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW. 1999. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 96:9879-9884.
39. Venters HD, Dantzer R, Kelley KW. 2000. Tumor necrosis factor-alpha induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor. Ann N Y Acad Sci 917:210-220.
40. Venters HD, Broussard SR, Zhou JH, Bluthe RM, Freund GG, Johnson RW, Dantzer R, Kelley KW. 2001. Tumor necrosis factor(alpha) and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts? J Neuroimmunol 119:151-165.
41. Vincent AM, Mobley BC, Hiller A, Feldman EL. 2004. IGF-1 prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 16:407-416.
42. Vuori K, Ruoslahti E. 1994. Association of insulin receptor substrate-1 with integrins. Science 266:1576-1578.
43. Wajant H, Scheurich P. 2001. Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Int J Biochem Cell Biol 33:19-32.
44. Wang HG, Rapp UR, Reed JC. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629-638.
45. Wang JY, Peruzzi F, Lassak A, Del Valle L, Radhakrishnan S, Rappaport J, Khalili K, Amini S, Reiss K. 2003. Neuroprotective effects of IGF-1 against TNFalpha-induced neuronal damage in HIV-associated dementia. Virology 305:66-76.
46. Wang MJ, Liu YX, Li XL, Shi J, Liu SL, Zheng DX. 2004. [Chemotherapeutic drugs enhanced rsTRAIL tumoricidal activity.] Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26:524-528.
47. You Z, Ouyang H, Lopatin D, Polver PJ, Wang CY. 2001. Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 276:26398-26404.
48. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628.